Search Results - "Bucki, Adam"

Photodegradation Assessment of Calcipotriol in the Presence of UV Absorbers by UHPLC/MS E.

Authors: Król, Małgorzata Żmudzki, Paweł Bucki, Adam et al.

Source: Applied Sciences (2076-3417); Aug2025, Vol. 15 Issue 15, p8124, 15p

Synthesis and biological evaluation of 2-fluoro and 3-trifluoromethyl-phenyl-piperazinylalkyl derivatives of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione as potential antidepressant agents.

Authors: Zagórska, Agnieszka Bucki, Adam Kołaczkowski, Marcin et al.

Source: Journal of Enzyme Inhibition & Medicinal Chemistry. 2016 Supplement, Vol. 31, p10-24. 15p.

Arylpiperazinylalkyl derivatives of 8-amino-1,3-dimethylpurine-2,6-dione as novel multitarget 5-HT/D receptor agents with potential antipsychotic activity.

Authors: Chłoń-Rzepa, Grażyna Bucki, Adam Kołaczkowski, Marcin et al.

Source: Journal of Enzyme Inhibition & Medicinal Chemistry. Dec2016, Vol. 31 Issue 6, p1048-1062. 15p.

Novel multitarget 5-arylidenehydantoins with arylpiperazinealkyl fragment: Pharmacological evaluation and investigation of cytotoxicity and metabolic stability.

Authors: Czopek, Anna Bucki, Adam Kołaczkowski, Marcin et al.

Source: Bioorganic & Medicinal Chemistry. Sep2019, Vol. 27 Issue 18, p4163-4173. 11p.

In Silico and In Vitro Assessment of Carbonyl Reductase 1 Inhibition Using ASP9521—A Potent Aldo-Keto Reductase 1C3 Inhibitor with the Potential to Support Anticancer Therapy Using Anthracycline Antibiotics.

Authors: Jamrozik, Marek Piska, Kamil Bucki, Adam et al.

Source: Molecules. May2023, Vol. 28 Issue 9, p3767. 14p.

Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1H-indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity.

Authors: Bucki, Adam Marcinkowska, Monika Śniecikowska, Joanna et al.

Source: Journal of Medicinal Chemistry. Sep2017, Vol. 60 Issue 17, p7483-7501. 19p.

Structural Modeling of TRPA1 Ion Channel—Determination of the Binding Site for Antagonists.

Authors: Gawalska, Alicja Kołaczkowski, Marcin Bucki, Adam

Source: Molecules. May2022, Vol. 27 Issue 10, p3077-3077. 19p.

JP-14: A Trace Amine-Associated Receptor 1 Agonist with Anti-Metabolic Disorder Potential.

Authors: Marcinkowska, Monika Sniecikowska, Joanna Głuch-Lutwin, Monika et al.

Source: International Journal of Molecular Sciences. Oct2025, Vol. 26 Issue 20, p10033. 32p.

Novel Dual 5-HT 7 Antagonists and Sodium Channel Inhibitors as Potential Therapeutic Agents with Antidepressant and Anxiolytic Activities.

Authors: Czopek, Anna Koczurkiewicz-Adamczyk, Paulina Wójcik-Pszczoła, Katarzyna et al.

Source: Pharmaceuticals (14248247). Oct2025, Vol. 18 Issue 10, p1485. 26p.

This result is not displayed to guests.
Login for full access.

Characteristics of metabolic stability and the cell permeability of 2‐pyrimidinyl‐piperazinyl‐alkyl derivatives of 1H‐imidazo[2,1‐f]purine‐2,4(3H,8H)‐dione with antidepressant‐ and anxiolytic‐like activities

Authors: Zagórska, Agnieszka Partyka, Anna Bucki, Adam et al.

Source: Chemical Biology & Drug Design. Apr2019, Vol. 93 Issue 4, p511-521. 11p.

Design, synthesis, and behavioral evaluation of dual-acting compounds as phosphodiesterase type 10A (PDE10A) inhibitors and serotonin ligands targeting neuropsychiatric symptoms in dementia.

Authors: Zagórska, Agnieszka Bucki, Adam Partyka, Anna et al.

Source: European Journal of Medicinal Chemistry. Apr2022, Vol. 233, pN.PAG-N.PAG. 1p.

Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD).

Authors: Bucki, Adam Marcinkowska, Monika Śniecikowska, Joanna et al.

Source: European Journal of Medicinal Chemistry. Apr2020, Vol. 191, pN.PAG-N.PAG. 1p.

Comparative study on ABCB1-dependent efflux of anthracyclines and their metabolites: consequences for cancer resistance.

Authors: Piska, Kamil Koczurkiewicz-Adamczyk, Paulina Jamrozik, Marek et al.

Source: Xenobiotica. 2023, Vol. 53 Issue 6/7, p507-514. 8p.

The use of machine learning-based sequential virtual screening in the search for new ligands of 5-HT6 receptor.

Authors: Sapa, Michał Gawalska, Alicja Kołaczkowski, Marcin et al.

Source: Farmacja Polska. 2022, Vol. 78 Issue 11, p607-614. 8p.

Serotonin 5-HT 6 Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity—Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer's Disease.

Authors: Więckowski, Krzysztof Szałaj, Natalia Gryzło, Beata et al.

Source: International Journal of Molecular Sciences. Aug2022, Vol. 23 Issue 16, p9443-N.PAG. 20p.

Impact of N-Alkylamino Substituents on Serotonin Receptor (5-HTR) Affinity and Phosphodiesterase 10A (PDE10A) Inhibition of Isoindole-1,3-dione Derivatives.

Authors: Czopek, Anna Partyka, Anna Bucki, Adam et al.

Source: Molecules. Sep2020, Vol. 25 Issue 17, p3868-3868. 1p.

Idalopirdine, a selective 5-HT6 receptor antagonist, reduces food intake and body weight in a model of excessive eating.

Authors: Kotańska, Magdalena Lustyk, Klaudia Bucki, Adam et al.

Source: Metabolic Brain Disease. Jun2018, Vol. 33 Issue 3, p733-740. 8p.

Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation.

Authors: Więckowska, Anna Kołaczkowski, Marcin Bucki, Adam et al.

Source: European Journal of Medicinal Chemistry. Nov2016, Vol. 124, p63-81. 19p.

Idalopirdine - a small molecule antagonist of 5-HT with therapeutic potential against obesity.

Authors: Dudek, Magdalena Marcinkowska, Monika Bucki, Adam et al.

Source: Metabolic Brain Disease. Dec2015, Vol. 30 Issue 6, p1487-1494. 8p.